Arlen Specter: “I do intend to pursue the expedited procedure. One of the items that I agree with the Senator from Arkansas on is how…”

“I do intend to pursue the expedited procedure. One of the items that I agree with the Senator from Arkansas on is how much time has passed here. I think that his cause might be advanced by accepting the burden of proof on the generic manufacturer and allowing this litigation to go forward with the provision for expedited procedures, and then damages for any time that the generic manufacturers are denied entry into the market after a substantial investment had been made, as determined in judicial proceedings, because what is happening now is that there have been lengthy proceedings in the Judiciary Committee. We have a very busy calendar. The managers of this bill want to move ahead with the Department of Defense authorization bill. But having brought this matter to the floor, it is an important one which merits at least this much discussion. We think that the Members could come to an agreement and find some way to expedite a legislative determination, which even if the burden is shifted to the generics--and they have to establish the judicial determination first--it may be very much more to the Senator's advantage than having this matter go over from today to sometime in the future.”